Copyright
©The Author(s) 2019.
World J Gastroenterol. Aug 7, 2019; 25(29): 3897-3919
Published online Aug 7, 2019. doi: 10.3748/wjg.v25.i29.3897
Published online Aug 7, 2019. doi: 10.3748/wjg.v25.i29.3897
Figure 1 Pharmacological features of direct-acting antiviral agents available in Ukraine and some Commonwealth of Independent States regions.
DAA: Direct-acting antiviral agents; CIS: Commonwealth of Independent States; HCV: Hepatitis C virus; RNA: Ribonucleic acid; Tmax: Time required to reach the peak plasma concentration of the drug; LDV: Ledipasvir; RBV: Ribavirin; SOF: Sofosbuvir; ESRD: End-stage renal disease; OD: Once-daily; CYP: Cytochrome P; MOA: Mechanism of action.
- Citation: Colombo MG, Musabaev EI, Ismailov UY, Zaytsev IA, Nersesov AV, Anastasiy IA, Karpov IA, Golubovska OA, Kaliaskarova KS, AC R, Hadigal S. Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions. World J Gastroenterol 2019; 25(29): 3897-3919
- URL: https://www.wjgnet.com/1007-9327/full/v25/i29/3897.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i29.3897